Description
1. Description
URIDOT-PLUS Tablet combines Tamsulosin 0.4mg + Dutasteride 0.5mg, two medicines used in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland. Tamsulosin helps relax smooth muscle around the prostate and bladder neck, while dutasteride reduces dihydrotestosterone (DHT), a hormone involved in prostate enlargement.
This combination may be prescribed for eligible adult men who need relief from urinary symptoms and treatment that helps reduce prostate volume over time. Symptoms may include a weak urine stream, difficulty starting urination, frequent urination and incomplete bladder emptying. Clinical response varies, and dutasteride generally takes several months to produce its full effect. This medicine does not treat prostate cancer or provide immediate relief from acute urinary retention.
CardianCare provides a contact point for pharmaceutical product and trade enquiries. Businesses researching a Tamsulosin 0.4mg + Dutasteride 0.5mg Tablets manufacturer India can enquire about product availability, approved specifications, manufacturing-source details and applicable quality documentation.
For procurement teams evaluating a Tamsulosin 0.4mg + Dutasteride 0.5mg Tablets manufacturer and supplier India, important considerations include the accuracy of both active ingredients, the modified-release characteristics of tamsulosin, product authorization, packaging, batch traceability and shelf life.
2. Key Ingredients
Composition: Tamsulosin 0.4mg + Dutasteride 0.5mg
Tamsulosin 0.4 mg Modified Release
Tamsulosin is an alpha-1 adrenergic receptor blocker. It relaxes smooth muscle in the prostate and bladder neck, helping reduce resistance to urine flow and improve urinary symptoms associated with BPH.
The modified-release formulation is designed to release tamsulosin according to its approved formulation characteristics. Administration must follow the instructions for the specific product.
Dutasteride 0.5 mg
Dutasteride is a 5-alpha-reductase inhibitor. It blocks the conversion of testosterone into dihydrotestosterone (DHT), a hormone that contributes to prostate growth. Lower DHT levels can gradually reduce prostate volume and the risk of BPH-related urinary complications in suitable patients.
Businesses researching a Tamsulosin 0.4mg + Dutasteride 0.5mg pharmaceutical company India should assess the complete composition, approved labelling, formulation specifications and relevant regulatory documentation.
Companies evaluating a Tamsulosin 0.4mg + Dutasteride 0.5mg medicine manufacturer India should verify the legal manufacturing source, product authorization, applicable quality standards and batch documentation before procurement.
3. Key Benefits
Urinary symptom relief: Tamsulosin helps relieve symptoms such as weak urine flow and difficulty starting urination associated with BPH.
Support for prostate-volume reduction: Dutasteride lowers DHT levels and may gradually reduce prostate volume.
Complementary mechanisms: The two active ingredients work through different mechanisms to address urinary symptoms and prostate enlargement.
Long-term BPH management: In appropriately selected patients, combination treatment may reduce the risk of BPH progression and related complications.
Improved urinary flow: Relaxation of smooth muscle around the prostate and bladder neck helps reduce resistance to urine flow.
Clinician-directed combination therapy: Provides a combination treatment option for eligible patients when both components are clinically appropriate.
Benefits depend on the patient’s prostate size, symptoms, medical history and response to treatment. Dutasteride may take months to provide its full benefit, and treatment requires appropriate follow-up.
Pharmaceutical buyers searching for a Tamsulosin 0.4mg + Dutasteride 0.5mg supplier India should verify current availability, product authenticity, approved specifications, shelf life and relevant documentation.
A Tamsulosin 0.4mg + Dutasteride 0.5mg Tablet wholesaler and distributor India enquiry may involve stock availability, minimum order quantities, delivery coverage, licensing requirements and commercial terms.
Businesses seeking a Tamsulosin 0.4mg + Dutasteride 0.5mg bulk supplier India should request a formal quotation and confirm packaging specifications, storage requirements, batch traceability and applicable quality documentation.
A Tamsulosin 0.4mg + Dutasteride 0.5mg pharmaceutical distributor India should verify distribution eligibility, product authorization and approved promotional information before commencing commercial activities.
4. How Does It Work?
The combination works through two complementary mechanisms:
Tamsulosin: Blocks alpha-1 adrenergic receptors in smooth muscle around the prostate and bladder neck. This relaxes the tissues and reduces resistance to urine flow, helping relieve urinary symptoms.
Dutasteride: Inhibits type 1 and type 2 5-alpha-reductase enzymes, reducing the conversion of testosterone into DHT. Reduced DHT levels can gradually decrease prostate volume and help limit BPH progression.
Tamsulosin may improve urinary symptoms relatively early, while dutasteride generally takes several months to achieve its full effect. The combination is intended for appropriately selected patients under medical supervision.
5. Directions for Use
Dosage: Take only as prescribed by a doctor. The clinician determines whether combination treatment is appropriate based on symptoms, prostate assessment and medical history.
Administration: Follow the approved product leaflet. Tamsulosin modified-release products have formulation-specific administration instructions, and the directions for the combined product must be followed.
Swallowing: Do not crush, chew or split the modified-release dosage form unless the approved instructions explicitly permit it.
Regular timing: Take the medicine consistently according to the prescribed schedule.
Missed dose: Follow the patient leaflet or advice from a healthcare professional. Do not double the next dose.
Monitoring: Attend follow-up appointments to assess symptom response, adverse effects and prostate health.
Treatment duration: Do not stop, restart or alter treatment without medical advice.
Dutasteride may affect prostate-specific antigen (PSA) blood test results. Inform the clinician conducting or interpreting PSA testing that you are taking dutasteride.
6. Possible Side Effects
Possible side effects associated with tamsulosin include:
Dizziness or light-headedness
Postural hypotension, particularly when standing up
Abnormal ejaculation, including reduced or absent ejaculation
Headache
Nasal congestion or a runny nose
Possible side effects associated with dutasteride include:
Reduced libido
Erectile dysfunction
Ejaculation disorders
Breast tenderness or enlargement
Important safety concerns
Fainting or severe dizziness: Seek prompt medical assessment, especially if symptoms are severe or persistent.
Breast changes: Report breast lumps, pain, enlargement or nipple discharge to a healthcare professional.
Allergic reactions: Swelling of the face or throat, rash with significant symptoms, or difficulty breathing requires urgent medical attention.
Cataract surgery: Inform the ophthalmologist about current or previous tamsulosin use because it has been associated with intraoperative floppy iris syndrome.
Prostate cancer assessment: Dutasteride can lower PSA levels. Changes in PSA must be interpreted by a healthcare professional familiar with the treatment.
Persistent symptoms: Difficulty passing urine, blood in the urine, fever or severe urinary pain requires medical assessment.
This list is not exhaustive. Consult a healthcare professional for advice about persistent or concerning symptoms.
7. Safety Information
Medical supervision: Use only under the guidance of a qualified healthcare professional.
Contraindications and allergies: Follow the approved product information. Do not use in patients with known serious hypersensitivity to either active ingredient or any formulation component.
Pregnancy: Dutasteride is contraindicated in women who are or may be pregnant because exposure can harm the development of a male fetus. Pregnant women should not handle leaking capsules containing dutasteride. Follow the specific product’s handling instructions.
Breastfeeding: This combination is intended for men with BPH and is not indicated for routine use in women. Seek medical advice if exposure or use is a concern.
Liver health: Inform the doctor about liver disease, as it may affect treatment suitability and monitoring.
Kidney health: Inform the prescriber about kidney disease and all existing medical conditions so the treatment can be assessed appropriately.
Blood pressure: Tamsulosin may cause dizziness or low blood pressure, particularly when combined with other alpha-blockers, antihypertensives or medicines such as sildenafil and tadalafil.
Drug interactions: Provide a complete list of prescription medicines, over-the-counter medicines and supplements. Medicines affecting CYP3A4 or CYP2D6 may alter tamsulosin exposure; certain medicines may also affect dutasteride Metabolism.
Blood donation: Patients taking dutasteride should follow the approved product guidance regarding blood donation, including restrictions during treatment and for the specified period after the last dose.
PSA monitoring: Dutasteride lowers PSA levels. Tell the healthcare professional about its use before prostate-related investigations.
Storage: Store in the original packaging according to the approved label, protect from excessive heat and moisture as directed, and keep out of children’s reach. Follow the specific product instructions for handling and disposal.
This information is educational and does not replace the approved prescribing information or individualized medical advice.
8. B2B Pharmaceutical Business Enquiries
CardianCare provides a contact point for pharmaceutical product and trade enquiries. Doctors, pharmacists, procurement teams, wholesalers, distributors and eligible pharmaceutical business partners can contact the company to ask about current product availability and applicable commercial arrangements.
Businesses researching a Tamsulosin 0.4mg + Dutasteride 0.5mg PCD pharma franchise India opportunity should confirm directly whether the product and a relevant programme are available, including territory eligibility, partner requirements and commercial terms.
For a Tamsulosin 0.4mg + Dutasteride 0.5mg Tablets PCD pharma franchise enquiry, prospective partners can request information about product availability, minimum order quantities, licensing requirements, distribution eligibility and any applicable promotional support.
Companies exploring a Tamsulosin 0.4mg + Dutasteride 0.5mg Tablet PCD franchise should verify programme availability and product eligibility before making investment or promotional commitments.
Businesses evaluating Tamsulosin 0.4mg + Dutasteride 0.5mg third party manufacturing India services should first confirm whether the proposed company offers such arrangements. Due diligence should cover manufacturing authorization, product approvals, modified-release formulation controls, applicable GMP compliance and quality documentation.
A Tamsulosin 0.4mg + Dutasteride 0.5mg Tablet third party manufacturer India enquiry should address the manufacturing facility’s regulatory status, formulation controls, quality systems, batch-release procedures, packaging specifications and contractual responsibilities.
Companies investigating Tamsulosin 0.4mg + Dutasteride 0.5mg contract manufacturing India should confirm service availability and discuss formulation specifications, release characteristics, technical documentation, quality agreements, regulatory responsibilities and commercial feasibility with the proposed manufacturing partner.
Contact CardianCare through its official website to enquire about current product availability, pharmaceutical distribution opportunities and applicable business arrangements. PCD franchise, third-party manufacturing and contract manufacturing services must be confirmed directly before being represented as available.
9. For More Information
For more information about URIDOT-PLUS Tablet (Tamsulosin 0.4mg + Dutasteride 0.5mg), click here












Reviews
There are no reviews yet.